Of mice and men: is there a future for metformin in the treatment of hepatic steatosis?

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver diseases, of which the first stage is steatosis. It is one of the most common liver diseases in developed countries and there is a clear association between type 2 diabetes (T2DM) and NAFLD. It is estimated that 70% of people...

詳細記述

書誌詳細
主要な著者: Green, C, Marjot, T, Tomlinson, J, Hodson, L
フォーマット: Journal article
言語:English
出版事項: Wiley 2018

類似資料